Agents and Actions

, Volume 24, Issue 1–2, pp 123–129 | Cite as

Characterization of a polyacrylamide gel-induced granuloma in mice: Involvement of arachidonate metabolites

  • M. Errasfa
  • F. Russo-Marie
Immunosuppression and Inflammation


The injection of polyacrylamide gel (Bio Gel P-4, 200–400 mesh) into the subcutaneous area of mice, induced an inflammatory reaction which was characterized by the migration of leukocytes (mainly neutrophils) from the blood vessels towards the polyacrylamide gel. A rapid protein accumulation was observed during the migration of cells towards the inflamed site. Neutrophils released some pro-inflammatory lipids (prostaglandins, leukotriene B4) and lysozyme, these products were assayed in the granuloma exudate at various times of the granuloma formation. In our experimental inflammatory model, the results suggest that neutrophils that are attracted by the polyacrylamide gel produce eicosanoids and lysozyme, which could act synergistically to potentiate cell migration and protein accumulation in the inflamed site.


Lipid Blood Vessel Prostaglandin Polyacrylamide Cell Migration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    E. Fontan and R.M. Fauve,Inflammation et résistance antibactérienne, Ann. Immunol. (Inst. Pasteur)134C, 255–264 (1983).Google Scholar
  2. [2]
    R. Vinegar, J.F. Truax and J.L. Selph,Some quantitative temporal characteristics of carrageenan-induced pleurisy in the rats, Proc. Soc. Exp. Biol. Med.143, 711–714 (1973).PubMedGoogle Scholar
  3. [3]
    R. Vinegar, J.F. Truax, J.L. Selph and A. Voelker,Pathway of onset, development, and decay of carrageenan pleurisy in the rat. Fed. Proc.41, 2588–2594 (1982).PubMedGoogle Scholar
  4. [4]
    G.A. Higgs and J.A. Salmon,Cyclo-oxygenase products in carrageenan-induced inflammation, Prostaglandins17, 737–746 (1979).Google Scholar
  5. [5]
    S. Tsurufuji, S. Yoshino and K. Ohuchi,Induction of an allergic air-pouch inflammation in rats. Int. Arch. Allergy Appl. Immunol.69, 189–198 (1982).PubMedGoogle Scholar
  6. [6]
    N.S. Doherty, P. Poubelle, P. Borgeat, T.H. Beaver, G.L. Westrich and N.L. Schrader,Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E 2, Prostaglandins30, 769–789 (1985).PubMedGoogle Scholar
  7. [7]
    T.J. Williams,Prostaglandin E 2,prostaglandin I 2 and the vascular changes of inflammation, Br. J. Pharm.65, 517–524 (1979).Google Scholar
  8. [8]
    M. Hamberg, J. Svensson and B. Samuelsson,Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxydes, Proc. Natl. Acad. Sci. USA72, 2994–2998 (1975).PubMedGoogle Scholar
  9. [9]
    S. Moncada, R.J. Gryglewski, S. Bunting and J. R. Vane,An enzyme isolated from arteries transforms prostaglandin endoperoxydes to an unstable substance that inhibits platelet aggregation, Nature263, 663–665 (1976).PubMedGoogle Scholar
  10. [10]
    A.W. Ford-Hutchinson, M.A. Bray, M.V. Doing, M.E. Shipley and M.J.H. Smith,Leukotriene B 4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature (London)286, 264–265 (1980).Google Scholar
  11. [11]
    R.M.J. Palmer, R.J. Stepney, G.A. Higgs and K.E. Eakins,Chemokinetic activity of arachidonic lipoxygenase products on leukocytes of different species, Prostaglandins20, 411–418 (1980).PubMedGoogle Scholar
  12. [12]
    P.A. Simmons, J.A. Salmon and S. Moncada,The release of leukotriene B 4 during experimental inflammation, Biochem. Pharmac.32, 1353–1359 (1983).Google Scholar
  13. [13]
    P.M. Brooks, D. Burton and M. J. Forest,Crystal-induced inflammation in the rat subcutaneous air-pouch, Br. J. Pharmac.90, 413–419 (1987).Google Scholar
  14. [14]
    R.M. Fauve, H. Jusforgues and B. Hevin,Maintenance of granuloma macrophages in serum-free medium. J. immunol. Methods64, 345–351 (1983).PubMedGoogle Scholar
  15. [15]
    S.B. Tucker, R.V. Pierre and R.E. Jordan,Rapid identification of monocytes in a mixed mononuclear cell preparation, J. Immunol. Methods14, 267–269 (1977).PubMedGoogle Scholar
  16. [16]
    H. Sors, P. Pradelles and F. Dray,Analytical methods for thromboxane B 2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry, Prostaglandins16, 277–280 (1978).PubMedGoogle Scholar
  17. [17]
    J.A. Salmon, P.M. Simmons and R.M.J. Palmer,A radioimmunoassay for leukotriene B 4, Prostaglandins24, 225–235 (1982).PubMedGoogle Scholar
  18. [18]
    M. Bradford,A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem.72, 248–254 (1976).PubMedGoogle Scholar
  19. [19]
    G. Litwack,Photometric determination of Lysozyme activity, Proc. Soc. Exp. Biol. Med.89, 401–405 (1955).PubMedGoogle Scholar
  20. [20]
    F. Hérodin, P. Calvas, D. Dormont et R.M. Fauve,Inflammation sous-cutané induite chez la souris par le polyacrylamide, Ann. Immunol. (Inst. Pasteur)134C, 401–410 (1983).Google Scholar
  21. [21]
    M. A. Bray, F. M. Cunningham, A. W. Ford-Hutchinson and M. J. H. Smith,Leukotriene B 4:a mediator of vascular permeability. Br. J. Pharm.72, 483–486 (1981).Google Scholar
  22. [22]
    C.V. Wedmore and T.J. Williams,Control of vascular permeability by polymorphonuclear leukocytes in inflammation, Nature289, 646–650 (1981).PubMedGoogle Scholar
  23. [23]
    G.A. Higgs, S. Moncada, J.A. Salmon and K. Seager,The source of thromboxane and prostaglandins in experimental inflammation, Br. J. Pharmac79, 863–868 (1983).Google Scholar

Copyright information

© Birkhäuser Verlag 1988

Authors and Affiliations

  • M. Errasfa
    • 1
  • F. Russo-Marie
    • 1
  1. 1.Unité de pharmacologie cellulaireUnité associée Institut Pasteur/INSERM no 285ParisFrance

Personalised recommendations